0000899243-20-017449.txt : 20200622
0000899243-20-017449.hdr.sgml : 20200622
20200622194123
ACCESSION NUMBER: 0000899243-20-017449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200618
FILED AS OF DATE: 20200622
DATE AS OF CHANGE: 20200622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOK DAVID N
CENTRAL INDEX KEY: 0001233684
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39333
FILM NUMBER: 20980039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Forma Therapeutics Holdings, Inc.,
CENTRAL INDEX KEY: 0001538927
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 371657129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
STREET 2: SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-679-1970
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
STREET 2: SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Forma Therapeutics Holdings LLC
DATE OF NAME CHANGE: 20120106
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-18
0
0001538927
Forma Therapeutics Holdings, Inc.,
FMTX
0001233684
COOK DAVID N
C/O FORMA THERAPEUTICS HOLDINGS, INC.
500 ARSENAL STREET, SUITE 100
WATERTOWN
MA
02472
0
1
0
0
SVP, Chief Scientific Officer
Stock Option (Right to Buy)
20.00
2020-06-18
4
A
0
23378
0.00
A
2030-06-17
Common Stock
23378
0
D
25% of the shares subject to the stock option shall vest on June 18, 2021 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.
/s/ Jeannette Potts, as Attorney-in-Fact
2020-06-22